FDA 483 - SpaceBander Corporation - June 02, 2022

An FDA inspection of SpaceBander Corporation in Hillsborough, NJ, revealed significant deficiencies in their quality system for medical devices. The firm failed to establish procedures for corrective and preventive actions, purchasing controls for their contract manufacturer, and document control. These issues indicate a lack of fundamental quality management processes.